Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes.
暂无分享,去创建一个
G. Maurer | K. Huber | U. Losert | J. Wojta | C. Kaun | R. Pacher | K. Macfelda | W. Speidl | T. Weiss | R. Ullrich | A. Fuernkranz | G. Rega | S. L. Grant | Christoph Springer | M. Marro | A. Rhodes | J. Bialy | Philipp Holzmann
[1] E. Furth,et al. Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice , 1996, Science.
[2] S. Akira,et al. Cytokine signal transduction , 1994, Cell.
[3] A. Yao,et al. Lipopolysaccharide augments expression and secretion of vascular endothelial growth factor in rat ventricular myocytes. , 2000, Biochemical and biophysical research communications.
[4] M. Gómez-Lechón,et al. Oncostatin M: signal transduction and biological activity. , 1999, Life sciences.
[5] M. Shibuya,et al. Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. , 1999, Biochemical and biophysical research communications.
[6] Y. Fujio,et al. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. , 1998, Circulation.
[7] Y. Fujio,et al. Hypoxic stress induces cardiotrophin-1 expression in cardiac myocytes. , 1999, Biochemical and biophysical research communications.
[8] M. Shibuya,et al. Interleukin-1βUpregulates Cardiac Expression of Vascular Endothelial Growth Factor and its Receptor KDR/flk-1 via Activation of Protein Tyrosine Kinases , 1999 .
[9] C. Begley,et al. The oncostatin M signalling pathway: reversing the neoplastic phenotype? , 1999, Molecular medicine today.
[10] Y. Fujio,et al. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. , 1996, Circulation.
[11] Jian Li,et al. Stretch-induced VEGF expression in the heart. , 1997, The Journal of clinical investigation.
[12] S. Akira,et al. Keratinocyte‐specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis , 1999, The EMBO journal.
[13] J. Ross,et al. Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress , 1999, Cell.
[14] Y. Fujio,et al. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. , 1997, The Journal of clinical investigation.
[15] E. Keshet,et al. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. , 1994, Cardiovascular research.
[16] G. Maurer,et al. Plasminogen Activator Inhibitor 1 Expression is Regulated by the Inflammatory Mediators Interleukin-1α, Tumor Necrosis Factor-α, Transforming Growth Factor-β and Oncostatin M in Human Cardiac Myocytes ☆ , 2002 .
[17] MotoakiSano,et al. Mechanical Stretch Activates the JAK/STAT Pathway in Rat Cardiomyocytes , 1999 .
[18] 大杉 友顕. Cardiac-specific Activation of Signal Transducer and Activator of Transcription 3 Promotes Vascular Formation in the Heart , 2002 .
[19] P. Carmeliet,et al. Molecular Basis of Angiogenesis: Role of VEGF and VE‐Cadherin , 2000, Annals of the New York Academy of Sciences.
[20] 正史 渋谷. 血管新生とその制御―VEGF と受容体を中心に― , 2004 .
[21] M. Ichihara,et al. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. , 1997, Blood.
[22] K. Shiota,et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[23] Yusu Gu,et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] S. Akira,et al. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[25] C. Begley,et al. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells , 2002, Oncogene.
[26] Willem Flameng,et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 , 1999, Nature Medicine.
[27] J. Turkson,et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.
[28] M. Goldberg,et al. Regulation of vascular endothelial growth factor in cardiac myocytes. , 1995, Circulation research.
[29] P. Linsley,et al. Oncostatin M. , 1992, Progress in growth factor research.
[30] A. Harken,et al. Reduction of infarct size in the rat heart by LPS preconditioning is associated with expression of angiogenic growth factors and increased capillary density. , 1999, Shock.
[31] Y. Fujio,et al. Activation of gp 130 Transduces Hypertrophic Signals via STAT 3 in Cardiac Myocytes , 1998 .
[32] Y. Fujio,et al. Activation of Phosphatidylinositol 3-Kinase through Glycoprotein 130 Induces Protein Kinase B and p70 S6 Kinase Phosphorylation in Cardiac Myocytes* , 1998, The Journal of Biological Chemistry.
[33] C. Frelin,et al. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. , 1993, Biochemical and biophysical research communications.
[34] M. Okabe,et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[35] U. Ikeda,et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. , 2000, Journal of the American College of Cardiology.
[36] R. Lindberg,et al. Cloning and Characterization of a Specific Receptor for Mouse Oncostatin M , 1998, Molecular and Cellular Biology.
[37] J. Burnett,et al. Cardiotrophin-1 Stimulation of Cardiac Fibroblast Growth: Roles for Glycoprotein 130/Leukemia Inhibitory Factor Receptor and the Endothelin Type A Receptor , 2002, Circulation research.
[38] A. Aitken,et al. The Generation and Characterization of Antagonist RNA Aptamers to Human Oncostatin M* , 2000, The Journal of Biological Chemistry.
[39] Y. Fujio,et al. Signal Transducer and Activator of Transcription 3 Is Required for Glycoprotein 130-mediated Induction of Vascular Endothelial Growth Factor in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.